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ABSTRACT 
Clinical research is focused in generating evidence that is feasible to 
be applicable to practitioners. However, translating research-focused 
evidence into practice may be challenging and often misleading. This 
article aims is to pinpoint these challenges and suggest some metho-
dological safeguards, taking platelet-rich plasma therapies and knee 
osteochondral injuries as examples. Studies and systematic reviews 
involving the following concepts will be investigated: clinically rele-
vant outcomes, systematic errors on sample calculation, internal and 
external validity. Relevant studies on platelet-rich plasma for muscle-
-tendon lesions and updates on osteochondral lesions treatment were 
included in this analysis. Authors and clinicians should consider these 
concepts for the implementation and application of dissemination 
of the best evidence. Research results should be challenged by a 
weighted analysis of its methodological soundness and applicability. 
Level of Evidence V, Therapeutic Studies - Investigating the 
Results of Treatment.
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INTRODUCTION
Outcome is defined as the final event of an intervention (of an 
experimental study) or of an observation (of an observational 
study).1 Currently, relevant outcome is understood as that effect is 
important to the patient, such as function and/or quality of life.2,3
It is known that these are the best parameters to translate 
treatment effectiveness, because they consider the evaluation 
– subjective and reported by the patient – as the most relevant 
to health care.2 On orthopedics research, it is a surgeon task 
to decide which outcome is relevant for the studied clinical 
condition, despite this decision is often a challenge.
The defiance about the choice of the best measure for outcome 
– that results in an applicable evidence on daily practice (external 
validity)4 is grounding extensive surgical clinical research. Nume-
rous publications devoted to “research on research“, example 
of metalanguage applied to medical science, are dedicated to 
solving the translational gap between ideal environment research 
(effective results) and clinical practice (actual results).5-7
However, systematic reviews and evidence-based guidelines 
are redundant to show that part of the current research does 
not address the relevant outcomes to clinical practice, resul-
ting in waste of human and economic.8-10 In this context, the 
ethical implications of conducting research without relevance 
or optimization of objectives may not be forgotten.11-13
Since the 90’s, orthopedic-researchers aim at a paradigm 
shift from the “surgeon centered” to the “patient-centered” 
research.14-17 To make it possible, prolific efforts sedimented 
methodologies (e.g. randomization and blinding methods, 
intention to treat analysis) and tools (e.g. questionnaires and 
scales) which are sine qua non conditions for enthusiasts of 
based on evidences orthopedics.14,17-19
In the 2010’s, making a research following these above con-
cepts is to ratify the position sedimented by those pioneer 
researchers. Although the concept is well accepted in the 
scientific community, there are obstacles and pitfalls regarding 
methodology and its interpretation.18
This review aims to expose concepts, applied to the orthopedic 
traumatology reality, of clinical research centered in relevant 
results, with the patient as the main informant of his condition.
Paradigm shift: prioritizing patient-centered assessment
It is a consensus that clinical outcomes, such as range of 
motion, strength and bone healing do not reflect entirely the 
post intervention status and often led the orthopedic commu-
nity to misguided conclusions.2 The more complete concept 
takes into account the specific functional dimension (clinical 
condition or region) and / or overall quality of life (physical, 
mental and social aspects).5,20
Subjectively, let the patient judge his own condition leads us to 
avoid two major pitfalls: the interventor bias, evaluating their own 
interventions and their subsequent judgment of success or failure.
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As additional condition for the choice of a good outcome, 
attention should be given to the establishment of a robust 
method (internal validity) of hypothesis verification, what could 
increase the results applicability (external validity). One should 
opt for conducting the study so that it can be the most relia-
ble conditions of daily life, so that its effectiveness is proven. 
Some randomized clinical trials are often targets of criticism 
when conducted “very controlled” because their results can 
translate more efficiency than effectiveness. (Table 1)
How to measure these results? Sample calculation and 
clinical tools
For the evaluation of patient focused outcomes, a large num-
ber of general and specific clinical tools are available and 
validated for our population. (Table 2)
The clinical tools allow considering the patient in the trial of 
clinical interventions and strengthen the actions of the rese-
archer in evaluating what treatment method is the best. As a 
principle, it is recommended the use of specific tools (organ/
member/specific disease) instead of the general ones.5
As a complement, the practical use of these concepts, ari-
ses the concept of minimally significant clinical difference 
(MSCD), defined in 1989.21 The initial argument of its practi-
cal plausibility is the finding that frequently identified statistic 
differences do not reflect relevant clinical differences.2,21 The 
definition of MSCD is set up as:22 “the smallest difference in a 
punctuation / score in the domain of interest in which patients 
perceive the presence of benefit and would require a shift in 
treatment paradigm, in the absence of adverse side effects 
and excessive costs.”
Translation of the outcomes: clinically relevant differences
Clinical trials may include one single group or more than one 
group. When there is a comparison, there is a possibility of gene-
rating assertions regarding the effectiveness of an A intervention 
versus a B intervention. To allow this it is necessary to be sure 
that both groups are comparable, often randomly allocated.23
Randomization, in itself does not guarantee that the comparison 
between the groups is valid.24 Statistically, it is necessary that 
the groups present sufficient sample number, ideally calculated 
a priori. The challenges of this step are described in Table 3.
Researchers often opt for subgroups analysis. The data ob-
tained should be considered with caution.
Table 1. Concepts for methodological assessment.
Concept3,5 Definition
Internal validity Ability of a study to reduce the chance of systematic errors (bias) through the optimization of the research methods
 External 
validity
It is the ability of the result to generate reliable generalizations to its 
target population (applicability) 
Effectiveness Ability of an specific intervention to produce the expected results - used under normal circumstances (medical practice, for example)
Efficiency
Ability of an specific intervention to produce the expected results - 
when used under ideal circumstances (laboratory studies, clinical 
studies with very restricted methodology)
Table 2. Necessary characteristics to a questionnaire as a research tool.
Characteristics2,5 Description
Reproducibility 
(test-retest 
reliability)
Ability of different measurements to generate the same result under 
steady and constant conditions 
Validity
Ability of a test to measure what it proposes.
 It is subdivided into validity of: 
1. Contents: Subjective evaluation of whether the components of 
the test include content / size to be measured; 
2. Criterion: comparative evaluation against established "gold" 
standard; 
3. Constructive: Assessment if the components of the test are 
comparable to clinical parameters and / or laboratory parameters 
relevant to clinical condition, in the absence of a gold standard.
Responsiveness Ability of a test to demonstrate relevant differences to researchers, surgeons and patients 
Specificity Ability to demonstrate plausible differentials to the studied condition
Table 3. Sample number determination – difficulties and challenges.
Research scenario Characters
Insufficient sample 
number, difference 
detected between 
groups
The difference between the groups may have occurred at 
random, unreliable results. Frequent in unplanned subgroup 
analyzes *. TYPE I ERROR.
Insufficient sample size, 
no difference detected 
between the groups
The difference between groups was not detected because there are 
few individuals in the comparison groups. Increasing the sample size 
will detect these differences. Frequent scenario in surgery studies. 
TYPE II ERROR.
Sufficient sample size, 
calculation performed 
previously
Results are possibly extrapolated to clinical practice. Steps 
of evidence-based medicine should be applied to ensure the 
reliability of the final product. (1. Clinical question; 2. Searching 
the best evidence; 3. Critical analysis; 4. Application) There is 
the possibility to detect statistical differences without clinical 
relevance (see next topic).
Applied clinical research: platelet-rich plasma
Until present times, studies involving platelet rich plasma failed 
to demonstrate the effectiveness of this treatment modality for 
orthopedic conditions such as rotator cuff tears, lateral epi-
condylitis and knee ligament injuries.25 These studies – due to 
their recentness – are already focused on self-reported func-
tional outcomes, under the presented research protocol. Many 
of these, despite being presented with sophisticated research 
designs are research products with low sample number, which 
may lead the reader to reach erroneous conclusions. Further-
more, the concept of minimally significant clinical difference 
must be taken into account.
Meta-analysis involving patients who underwent application of 
platelet rich plasma demonstrated a statistical difference for 
the pain outcome (measured by analogue scale) for arthros-
copic rotator cuff repair, lateral epicondylitis, tendinopathy 
and rupture of the Achilles tendon. In this result - evaluated 
for up to three months, it was identified that the difference 
between the averages for allocation groups was - 0.95 with 
a confidence interval (95% CI) going from the minimum to 
maximum of -1.41 -0.48. 
Surgeons and researchers should reflect if a maximum diffe-
rence, in the most favorable scenario to Platelet-Rich Plasma 
of 1.41 brings benefit to justify the application of Platelet-Rich 
Plasma. In this meta-analysis, the authors indicate that this 
difference is marginal and that possibly does not translate into 
relevant clinical benefit.25 In this research spectrum, studies 
show that differences above 3 points are those that result in 
relevant clinical differences.2,26
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Applied clinical research: osteochondral knee lesions
The incidence of osteochondral lesions (OCL) of the knee 
are estimated at 900,000 per year in the United States of 
America27 and affect the population in different age groups 
with 36% greater prevalence in the population of athlets.28 The 
low capacity for regeneration of cartilage tissue, associated 
with frequent progression to osteoarthritis make these lesions 
widely studied and of great clinical interest issue currently.
When studying OCL in clinical trials, we must have in mind 
some confounding variables included in several clinical trials 
that are usually associated to patients with OCL, but should 
not be considered all together. An example that is frequently 
reported is the analysis on the anterior cruciate ligament (ACL) 
intervention associated with OCL,29,30 in which the treatment 
with ACL reconstruction can directly influence the results of 
cartilage repair and vice versa.
Osteochondritis dissecans (OCD) is another greatly mentio-
ned theme in clinical trials for treatment of cartilage injuries.31 
Given the different behavior of this disease compared to iso-
lated cartilage lesion, this patient population should be asses-
sed separately in the studies.
What if we do not get a significant sample to study the isola-
ted desired population? In these cases the ideal is to create 
subgroups in the same analysis in order to isolate the effect of 
each population. An example of a clinical trial is: Micro-fracture 
versus mosaicoplasty in isolated chondral injury and OCD. 
When assaying these patients, analysis of groups for isolated 
chondral injury and OCD should be separated.
The main or primary outcomes in LOC clinical studies should 
be the patient’s function, quality of life and treatment com-
plications. Functional outcomes are assessed by functional 
scores - among which the most used are the Western Ontario 
and McMaster Universities questinnaire-WOMAC,32 the Inter-
national cartilage repair score-ICRS SCORE, the Knee injury 
and osteoarthritis outcomes score-KOOS,33 the International 
knee documentation Committee subjective knee evaluation 
form - IKDC34 and the Lysholm knee scoring scale-LYSHOLM35 
- some presented on Table 4.36-41 The quality of life can be 
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Table 4. Instruments for functional scores assessment.
Instrument Description
DASH (Disability of arm, 
shoulder and hand) 
Region-specific questionnaire, self-applied. Translated and validated into Brazilian Portuguese, in a population with rheumatoid arthritis. Measures dysfunction of the arm, shoulder 
and hand. Its evaluation considers activity of both upper limbs, globally. Has additional (optional) modules addressing sports, music and work performance. There is good correlation 
between full version and summarized version (Quick DASH).
PRWE  (Patient-rated wrist 
evaluation score) 
Region-specific questionnaire, self-applied. Translated into Brazilian Portuguese. It still has to be validated. Initially idealized for distal radius fractures, measures dysfunctions of the 
affected wrist. Approaches pain and function. There are studies demonstrating good psychometric qualities. Adequate correlation with SF-36 and DASH.
CONSTANT – MURLEY 
(Constant-Murley 
questionnaire) 
Region-specific questionnaire, applied by the interviewer. Initially indicated for all shoulder conditions; however, there was the development of disease-specific scores, such as 
WORC (for the rotator cuff) and ROWE (for instability). It assesses pain, everyday life activities, strength and range of motion. Studies show good reproducibility, despite it lacks 
specificity for shoulder instability.
MHQ (Michigan hand 
questionnaire) 
Region-specific questionnaire, self-applied. Indicated for general assessment of all conditions of the hand. Evaluates pain, function, esthetic and satisfaction. Unlike the DASH 
questionnaire, it rates separately left and right hands.
BHQ (Boston Carpal Tunnel 
Questionnaire, Levine-Katz 
Questionnaire)
Disease-specific questionnaire self-applied or applied by the interviewer. Evaluates function and symptoms. There is extensive literature validating this tool, with good correlation 
with the SF-36 and DASH. Indicated for evaluation of patients with carpal tunnel syndrome.. 
WORC (Western Ontario 
Rotator Cuff Index)
Disease-specific questionnaire, for rotator cuff evaluation. It is the most used of Western Ontario Shoulder Indexes, which also includes tools for instability (WOSI) and osteoarthritis 
(WOOS) of the shoulder.
UCLA (University of 
California at Los Angeles 
Shoulder Rating Scale )
Region-specific questionnaire, self-reported. Used to assess shoulder function. Evaluates pain, function, range of motion/active flexion, strength/active flexion and satisfaction. The 
instrument is criticized due to the empirical generation of the questionnaire items, different weighing between the evaluated criteria without a supporting  methodological background.
SST (Simple Shoulder Test) Region-specific questionnaire, self-reported. Used for the evaluation of every shoulder condition of the shoulder. Consists of 12 “yes or no” questions. 
WOMAC
Region-specific questionnaire, self-applied. Validated for personal, phone, or electronic interview, through computer or cell phone. Translated and validated into Brazilian Portuguese.32,36 
Originally developed in 1982 to detect treatment response for osteoarthritis of hip and knee. Currently, it has been used for chondral lesions of the knee and injury of the anterior 
cruciate ligament (ACL). It is based in three parameters: pain during various movements and positions, severity of joint stiffness and difficulty in performing activities of daily living. 
The abridged version has been used but is not recommended by the WOMAC web site. The questionnaire is available on the website after request approval (http://www.womac.org).
IKDC (Subjective Knee 
Evaluation Form)
Region-specific questionnaire, self-applied and not validated for interviews. Translated and validated into Portuguese.34,37 Developed for various knee injuries. The IKDC addresses 
symptoms (pain, stiffness, edema, joint locking and instability) and daily and sports activities, current functions and functions prior to injury (the latter topic is not accounted for 
the score). Indicated for knee injuries (ACL, anterior cruciate ligament; PCL, posterior cruciate ligament, collateral ligaments, osteochondritis dissecans, knee sprain and meniscal 
lesion) and corrective interventions  (recosntructions of ACL, PCL, and collateral ligaments, meniscal repair, meniscectomy, chondral injury repair, platelet rich plasma infusion, tibial 
osteotomy and lateral release. Questionnaire available at http://www.sportsmed.org/tabs/research/ikdc.aspx 
Tegner
Questionnaire created for interviews, but currently self-applied. Developed in 1985 to assess the level of physical and sports activity of the patients. Originally suggested as a 
complement to the LYSHOLM score in patients with ACL injury. Based on a range of daily living, recreation and competitive sports activities that are identified to the patient habits. 
Available on the original publication.38
AOFAS
Questionnaire created in 1994 by a committee of the American Orthopedic Foot and Ankle Society (AOFAS). Divides the foot and ankle evaluation based on anatomical scales: hind 
foot and ankle, mid foot, metatarsal phalangeal (MF) and inter phalangeal (IF) of the hallux, MF and IF the smaller toes, which allows its use in several diseases and interventions 
of the foot and ankle. Translated in 2008, full text available in the original publication in Portuguese.39
Kujala
The Kujala score or scale of the anterior pain of the knee, developed in 1993  is a self-applied questionnaire. It features 13 items evaluated at rest and after specific activities such 
as walking, running, jumping, squatting, sitting for long periods and climbing stairs. Currently, it is widely used for clinical studies and for monitoring patients with patellofemoral 
or anterior knee pain. Translated and adapted into Portuguese in 2011.40 It is sensitive for anterior knee pain detection, but poor for differentiate recurrent patellar dislocation and 
single patellar dislocation. 
Lysholm
Region-specific questionnaire, self-applied. Validated for personal interview, but frequently used as self-applied. It assesses joint stability after ligament reconstructions. The revised 
scale has 8 categories: gait, support, joint locking, instability, pain, edema, climbing stairs and squatting. Currently used to assess ligament injuries (ACL, PCL and collateral), 
meniscal,chondral and knee dislocation. Used to evaluate interventions such as arthroscopy, ligament reconstruction, cartilage repair, tibial osteotomy, infusion of hyaluronic acid 
and therapeutic exercises. Translated and adapted into Portuguese. Full text publication available.35,41
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assessed by the SF-3642 or World Health Organization (WHO-
QoL) questionnaires. For treatment complications such as 
infection and stiffness, revision surgery should also be consi-
dered among the most important outcomes.
Many clinical trials on cartilage focus on less important end 
points for clinical studies, such as imaging studies and pos-
toperative biopsies. There is no question on the validity of 
these analysis for understanding the disease, but the clinical 
and radiological or clinical histological correlation are often 
very weak and do not express the functional outcome of 
these patients.43
FINAL CONSIDERATIONS
The incorporation of the above outlined concepts are impor-
tant for a good practice of MBE, both from the perspective 
of the researcher-orthopedist, as of the consumer of health 
information. It is an essential condition to conduct research 
in orthopedics and traumatology surgery.
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